Importantly, several reports have identified indoleamine 2,3-dioxygenase (IDO) as the targets of zebularine through which zebularine carried out immunomodulatory functions on cancer and autoimmunity treatments (29–31). The gene discussed is IDO1; the disease is Autoimmunity.